C4A and primary biliary cholangitis: The serum C4 response to oral CDCA administration was significant in HC (p = 0.018), in PBC patients (p < 0.001) and in the MRSlow subgroup (p = 0.006), but not in the MRSintermediate-high subgroup (p = 0.64).